![](/img/cover-not-exists.png)
PANGAEA: Post-authorization Noninterventional German Safety Study of GilEnyA in relapsing-remitting multiple sclerosis (RRMS) patients: A 24-month interim analysis of a German five-year fingolimod registry study
Ziemssen, T., Diaz-Lorente, M., Abdelkader, M., Cornelissen, C.Volume:
3
Language:
english
Journal:
Multiple Sclerosis and Related Disorders
DOI:
10.1016/j.msard.2014.09.182
Date:
November, 2014
File:
PDF, 46 KB
english, 2014